PubRank
Search
About
Jean Viallet
Author PubWeight™ 22.30
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.
Proc Natl Acad Sci U S A
2007
4.92
2
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.
Blood
2008
2.18
3
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).
Cancer Res
2008
2.17
4
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.
Clin Cancer Res
2008
1.77
5
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
Cancer Chemother Pharmacol
2007
1.49
6
Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma.
Clin Cancer Res
2010
1.35
7
Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
Oncol Rep
2007
1.12
8
The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.
Clin Cancer Res
2010
1.08
9
Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
Cancer Res
2013
1.07
10
Functional interaction of Aurora-A and PP2A during mitosis.
Mol Biol Cell
2007
1.01
11
Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer.
Hematology Am Soc Hematol Educ Program
2005
0.99
12
Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology.
Mol Pharmacol
2005
0.93
13
The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.
Autophagy
2010
0.86
14
Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.
PLoS One
2013
0.83
15
Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.
Br J Pharmacol
2013
0.80